Cardinal Health INC Form 4 insider transactions

NYSE
Director Sheri H. Edison reports the acquisition of 1,730 restricted share units of Cardinal Health, Inc.
NYSE
Director David C. Evans acquired 1,730 common shares of Cardinal Health Inc. through a grant of restricted share units.
NYSE
Patricia Hemingway Hall, a director at Cardinal Health, acquired 1,730 restricted share units on November 6, 2024, which will vest on November 6, 2025, or the date of the 2025 Annual Meeting of Shareholders if it occurs earlier.
NYSE
Director Akhil Johri reported acquiring 1,730 common shares of Cardinal Health Inc. through restricted share units.
NYSE
Gregory B. Kenny, a director at Cardinal Health Inc., was granted 2,812 restricted share units on November 6, 2024, which will vest on November 6, 2025, or the date of the 2025 Annual Meeting of Shareholders if it occurs earlier.
NYSE
Director Nancy Killefer reported acquiring 1,730 common shares of Cardinal Health Inc. on November 6, 2024, through a grant of restricted share units.
NYSE
Director Christine Mundkur acquired 1,730 common shares of Cardinal Health through a grant of restricted stock units.
NYSE
Jessica L. Mayer, Chief Legal/Compliance Officer of Cardinal Health Inc., sold 16,573 shares of common stock at an average price of $109.39 on August 21, 2024.
NYSE
Jessica L. Mayer, Chief Legal/Compliance Officer of Cardinal Health, reports the acquisition and disposal of company stock and derivative securities.
NYSE
Cardinal Health's CFO, Aaron E. Alt, reports the acquisition and disposal of company shares, including transactions related to restricted stock units and tax obligations.
NYSE
Michelle Greene, Chief Information Officer of Cardinal Health, reports the acquisition and disposal of company shares, including transactions related to vesting of restricted stock units and performance share units.
NYSE
Cardinal Health's CEO, Jason Hollar, reports the acquisition and disposal of company shares, including transactions related to vesting of restricted stock units and performance share units.
NYSE
Ola M. Snow, Chief Human Resources Officer at Cardinal Health, reports multiple transactions involving common shares and derivative securities, including acquisitions, disposals, and option exercises.
NYSE
Stephen M. Mason, CEO of the GMPD Segment at Cardinal Health, reports the acquisition and disposal of company shares, including transactions related to stock options and restricted stock units.
NYSE
Mary C. Scherer, Chief Accounting Officer of Cardinal Health, reports the acquisition and disposal of company shares to cover tax obligations and vesting of restricted stock units.
NYSE
Deborah Weitzman, CEO of PSS Segment at Cardinal Health, reports acquisition and disposal of company shares to cover tax obligations and vesting of restricted stock units.
NYSE
Deborah Weitzman, CEO of PSS Segment at Cardinal Health, reports acquiring and disposing of common shares on August 13, 2024, according to a Form 4 filing with the SEC.
NYSE
Michelle D. Greene, Chief Information Officer of Cardinal Health, acquired 2,785 common shares on August 13, 2024, through the settlement of performance share units.
NYSE
Ola M. Snow, Chief Human Resources Officer at Cardinal Health, reports acquiring and disposing of common shares, including performance share units settling on August 15, 2024.
NYSE
Mary C. Scherer, Chief Accounting Officer of Cardinal Health, acquired 2,785 common shares on August 13, 2024, through the settlement of performance share units.
NYSE
Stephen M. Mason, CEO of the GMPD Segment at Cardinal Health, reports acquiring and disposing of common shares on August 13, 2024.
NYSE
Jason M. Hollar, CEO of Cardinal Health, acquired 45,958 common shares on August 13, 2024, through the settlement of performance share units.
NYSE
Jessica L. Mayer, Chief Legal/Compliance Officer of Cardinal Health Inc., reports acquiring 41,780 common shares on August 13, 2024, and now beneficially owns 111,068 shares.
NYSE
Michelle D. Greene, Chief Information Officer of Cardinal Health, sold 664 common shares on March 15, 2024, to cover tax obligations related to vesting restricted share units.
NYSE
Robert Azelby, a director at Cardinal Health, acquired 1,288 restricted share units on March 15, 2024, which will vest on March 15, 2025.